Geneos Wealth Management’s Xtrackers MSCI All World ex US High Dividend Yield Equity ETF HDAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-68,572
Closed -$1.7M 2637
2024
Q2
$1.7M Buy
68,572
+7,085
+12% +$178K 0.08% 275
2024
Q1
$1.53M Buy
61,487
+4,253
+7% +$103K 0.07% 285
2023
Q4
$1.4M Buy
57,234
+2,101
+4% +$48.3K 0.07% 274
2023
Q3
$1.24M Buy
55,133
+6,199
+13% +$144K 0.06% 281
2023
Q2
$1.13M Buy
48,934
+10,328
+27% +$243K 0.06% 297
2023
Q1
$901K Buy
38,606
+6,653
+21% +$153K 0.05% 312
2022
Q4
$706K Buy
31,953
+12,265
+62% +$256K 0.04% 346
2022
Q3
$370K Buy
+19,688
New +$413K 0.03% 450

Geneos Wealth Management's HDAW Position: Q3 2024 in Review

Geneos Wealth Management sold out of Xtrackers MSCI All World ex US High Dividend Yield Equity ETF (HDAW) in Q3 2024, closing a stake of 68,572 shares — an estimated $1.7M sold.

Geneos Wealth Management first reported a position in HDAW in Q3 2022 and held it in 8 quarters. The position peaked at $1.7M in Q2 2024. 0 funds tracked by Wall St. Rank hold HDAW as of Q3 2024.

  • Geneos Wealth Management reported no remaining Xtrackers MSCI All World ex US High Dividend Yield Equity ETF position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 68,572 Xtrackers MSCI All World ex US High Dividend Yield Equity ETF shares in Q3 2024, an estimated $1.7M.
  • Geneos Wealth Management first reported a position in Xtrackers MSCI All World ex US High Dividend Yield Equity ETF in Q3 2022 and held it in 8 quarters.
  • Geneos Wealth Management's Xtrackers MSCI All World ex US High Dividend Yield Equity ETF position peaked at $1.7M in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Xtrackers MSCI All World ex US High Dividend Yield Equity ETF as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.